What Researchers Did
Researchers reviewed how they managed a rare complication called laryngeal chondroradionecrosis, which happens when radiation treatment damages the cartilage of the voice box.
What They Found
This retrospective single-center study found that among 678 patients irradiated for laryngeal cancer, 29 (4.3%) developed this complication. Primary management was most often tracheostomy with intravenous steroids and antibiotics (59%), while 10 patients (34.5%) received hyperbaric oxygen therapy and 6 patients (21%) underwent total laryngectomy. In the patients treated with hyperbaric oxygen, disease severity (measured by Chandler's grade) improved significantly, from a median of 4 down to 2.5 (p less than 0.005).
What This Means for Canadian Patients
For patients who develop this complication after radiation treatment for laryngeal cancer, the study suggests hyperbaric oxygen therapy may benefit those with persistent and unresponsive symptoms. The abstract does not report whether hyperbaric oxygen therapy changed the need for surgery or other management options, since these were tracked as separate, not directly compared, treatment groups.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a retrospective, single-center study without a controlled comparison between treatment groups, so it cannot establish that hyperbaric oxygen therapy caused the improvement seen.